Korea’s SK Chemicals Looks To Sell First Generic Patch Of Novartis’ Exelon In Europe
This article was originally published in PharmAsia News
Executive Summary
SK Chemicals has signed a deal with 12 European pharmaceutical companies to sell its Alzheimer’s patch SID710, which it says, will be the first generic patch of Novartis’ Exelon in Europe.